8th Apr 2014 07:00
Port Erin Biopharma Investments Limited
(the "Company")
Net Asset Value calculation to 31 March 2014
Jim Mellon, Chairman, commented: -
"The Net Asset Value ("NAV") calculation for the Company as at closing on 31 March 2014 was 15.40 pence per share, including un-invested cash of £736,392 and an accrual carried forward of £379,057 for the management fee. The portfolio is valued under IFRS at bid price. This quarter's NAV represents a decrease of 3.2% from the previous valuation of 15.91 pence per share, which included un-invested cash of £802,741. Our holding in the Magna Biopharma Income Fund continues to perform well, the value having risen by 6.2% in the quarter."
| Unaudited to 31 March 2014 £ | |
Fixed Assets |
|
|
| Investments
| 4,897,990
|
Current Assets |
|
|
| Debtors: amounts owing | 14,765 |
| Un-invested cash
| 736,392
|
Current Liabilities |
|
|
| Creditors: amounts due
| (433,455)
|
|
| 5,215,692
|
Capital and Reserves |
|
|
| Share Capital | 34 |
| Share Premium | 2,759,551 |
| Current year's earnings | 1,615,741 |
| Retained earnings
| 840,366 |
| 5,215,692
| |
| ||
Shares in Issue
| 33,864,836 | |
Asset Value per share | 15.40 pence | |
| ||
| ||
| ||
|
--- ENDS ---
Portfolio Details
Investments as at 31 March 2014 | Value | % of Total Portfolio |
Magna Biopharma Income Fund |
£2,917,568 |
59.6% |
Plethora Solutions Holdings | £852,500 | 17.4% |
Summit Corporation | £728,333 | 14.9% |
Other quoted holdings | £80,271 | 1.6% |
Other unquoted holdings | £319,318 | 6.5% |
TOTAL INVESTMENTS | £4,897,990 | 100.0% |
For further information, please contact:
Port Erin Biopharma Investments Limited | Beaumont Cornish Limited | Peterhouse Capital Limited |
The Company | Nomad | Broker |
Denham Eke +44 162 463 9396 | Roland Cornish Felicity Geidt +44 207 628 3396 | Jon Levinson +44 207 469 0935 |
Related Shares:
Agronomics